Effect of garcinol in delaying the progression of diabetic nephropathy
AssigneeDelhi Institute of Pharmaceutical Sciences and Research
InventorsSonia Gandhi, B.P. Srinivasan
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of garcinol as a nephroprotective agent. The present invention also relates to the use of garcinol as a therapeutic agent in renal disorders, in particular diabetic nephropathy, and to medicinal preparations containing garcinol. Further disclosed herein are method of treatment of renal disorders, in particular diabetic nephropathy by administration of garcinol.
Claims18
A method of using Garcinol comprising:
- selecting a subject in need of a nephroprotective agent;
- and
- providing said subject Garcinol.
2-20. (canceled)
A method of treating or delaying the progression of a renal disorder in a subject in need thereof comprising:
- selecting a subject having a renal disorder;
- and
- providing said subject Garcinol.
The method as claimed in 21, wherein the nitric oxide level is reduced in said subject subsequent to said subject receiving the Garcinol.
A composition comprising Garcinol and a pharmaceutically acceptable excipient, wherein said Garcinol in said composition is in the range of 100 mg to 1000 mg.
Dependencies are inferred from the claim text.